Silver State Dispatch
SEE OTHER BRANDS

The most trusted news from Nevada

Silver State Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Silver State Dispatch.

Press releases published on June 9, 2025

SHE’S GOT TIME ANNOUNCES THIRD ANNUAL WOMEN IN SPORTS SUMMIT JULY 14 - 15 IN LAS VEGAS; TICKETS ON SALE NOW

SHE’S GOT TIME ANNOUNCES THIRD ANNUAL WOMEN IN SPORTS SUMMIT JULY 14 - 15 IN LAS VEGAS; TICKETS ON SALE NOW

Founder …

XILERATE™ by xosialX: Redefining the Energy Drink Industry with Clean, Limitless Energy

XILERATE™ by xosialX: Redefining the Energy Drink Industry with Clean, Limitless Energy

A new era of energy: XILERATE™ fuels mind …

Comstock Amends Agreement With Mackay Precious Metals Inc.

Comstock Amends Agreement With Mackay Precious Metals Inc.

VIRGINIA CITY, Nev., June 09, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced it has amended the Membership Interest Purchase Agreement (the “MIPA”) to sell 100% of the northernmost patented and unpatented …

Revolutionizing Hair Restoration: Hall & Wrye Plastic Surgeons Introduces Allure Hair Restoration Services in Nevada

Revolutionizing Hair Restoration: Hall & Wrye Plastic Surgeons Introduces Allure Hair Restoration Services in Nevada

Hall …

Hyperscale Data Enters into Settlement Agreement that is Expected to Result in Defense Affiliate Gresham Worldwide Exiting Chapter 11 on or Before October 1, 2025; Updates 2025 Revenue Guidance to $125–$135 Million

Hyperscale Data Enters into Settlement Agreement that is Expected to Result in Defense Affiliate Gresham Worldwide Exiting Chapter 11 on or Before October 1, 2025; Updates 2025 Revenue Guidance to $125–$135 Million

LAS VEGAS, June 09, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced that the Company and Gresham Worldwide, Inc. (“Gresham Worldwide”), currently an …

Secura Bio Announces First Patient Dosed in Phase 3 TERZO Study of COPIKTRA® (duvelisib) in Relapsed/Refractory Nodal T-follicular Helper Cell Lymphoma

Secura Bio Announces First Patient Dosed in Phase 3 TERZO Study of COPIKTRA® (duvelisib) in Relapsed/Refractory Nodal T-follicular Helper Cell Lymphoma

SUMMERLIN, Nev., June 09, 2025 (GLOBE NEWSWIRE) -- Secura Bio, Inc. (www.securabio.com), an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announced that the first patient has been dosed in its Phase 3 TERZO …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service